Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50268-093

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50268-093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 01)

A cumulative incidence graph comparing Atorvastatin and placebo over a period of 3.5 years. The y-axis shows cumulative incidence percentage, and the x-axis represents years. The graph includes a hazard ratio (HR=0.64) with confidence intervals and a p-value for statistical significance.*

FDA Label Image

Figure-02 (Figure 02)

A line graph comparing cumulative hazard over time between placebo and atorvastatin groups. The x-axis represents years from 0 to 5 for time to first primary endpoint, and the y-axis shows cumulative hazard as a percentage from 0 to 15. The placebo group has a higher cumulative hazard, indicated by a dashed line, while the atorvastatin group is represented by a solid line with a lower cumulative hazard.*

FDA Label Image

Figure-03 (Figure 03)

A Kaplan-Meier curve graph illustrating the percentage of subjects experiencing a major cardiovascular event over time, comparing Atorvastatin 10 mg and 80 mg doses. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the cumulative percentage of subjects with events. The 80 mg dose shows a lower event rate than the 10 mg dose, with a hazard ratio of 0.78 (95% CI 0.69-0.89) and a p-value of 0.0002.*

FDA Label Image

Label 1 (Label 5026809315)

Packaging label for Atorvastatin Calcium Tablets 10 mg, film-coated oral tablets. The label shows a unit dose bottle containing 50 tablets (5 x 10). It includes storage directions and pharmacist dispensing instructions. Manufactured for AvPAK, Pulaski, TN, with NDC 50268-093-15.*

FDA Label Image

Label 2 (Label 5026809415)

Atorvastatin Calcium Tablets 20 mg film-coated tablets packaging label displaying the product name, strength, Rx Only status, and an NDC barcode. The label indicates a quantity of 50 tablets in unit dose packaging (5x10), storage instructions between 20°C to 25°C with permitted excursions, dispensing instructions, and manufacturer details for AvKARE, Inc., Pulaski, TN. The AvPAK brand logo is also visible.*

FDA Label Image

Label 3 (Label 5026809515)

Packaging label for Atorvastatin Calcium Tablets 40 mg, film-coated oral tablets. The label shows the product name, strength (40 mg), and quantity (50 tablets in 5 blister packs of 10). It includes storage instructions, dispensing notes, and manufacturer details for AvPAK, Pulaski, TN. The barcode and NDC number 50268-095-15 are visible.*

FDA Label Image

Label 4 (Label 5026809612)

ATVORVASTATIN CALCIUM 80 mg film-coated tablet label showing the NDC 50268-096-12. The label is for a 20-count package (4x5 unit dose) for oral use. It includes pharmacist dispensing instructions, storage conditions at 20° to 25°C with permitted excursions, and notes the manufacturer as AvKARE, Inc., Pulaski, TN. The label features the AvPAK logo and revision dates.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of atorvastatin calcium showing two atorvastatin molecules complexed with one calcium ion and one molecule of water.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.